Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Time from brand drug launch to generic patent challenges U.S. 1995-2014

Time from launching a brand drug to meeting a paragraph IV patent challenge in the U.S. from 1995 to 2014

by Matej Mikulic, last edited Jul 22, 2019
Time from brand drug launch to generic patent challenges U.S. 1995-2014 This statistic shows the average time from the launch of a new brand drug to the time that the patent is challenged by generic companies under paragraph IV certifications in the U.S. from 1995 to 2015. The average time from launch to having a drug patent challenged has decreased from 14.3 years as of 1995 to just 5.2 years as of 2014.
Show more

Time from launching a brand drug to meeting a paragraph IV patent challenge in the U.S. from 1995 to 2014

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Generics and biosimilars
Generics and biosimilars

All Information
in one Presentation

Generics and biosimilars

Everything On "Generics and biosimilars" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Generics and biosimilars"
  • Global overview
  • Top companies
  • U.S. market
  • Patent expiration
  • Savings
  • Biosimilars
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.